This application is for the renewal of a post-doctoral training grant at the University of Minnesota in diabetes, endocrinology, and metabolism that has been in existence since 1977. The long- standing goal of this program has been to prepare physicians and graduates of PhD programs for successful research careers in academic medicine. This preparation has been centered upon the critical interaction between the trainee and the research mentor. All mentors in this program have national or international reputations in their respective areas and have strong track records in mentoring. Their efforts are supported by a strong administrative structure that encourages trainees to be deliberate in obtaining the skills they will need to become independent investigators. This structure also regularly evaluates and monitors the success of the trainee and the overall program as well as supports the development of a highly interactive relationship between the trainee and mentor. The particular research strengths of our faculty include cellular metabolism and genetics;endocrinology and signaling;neurobiology and appetite regulation of obesity;stem cell biology, autoimmunity, and b-cell biology;and clinical aspects of endocrine disease. Most of our faculty are located in the clinical and basic departments within the Medical School, but new faculty from the School of Public Health and the College of Food, Agricultural and Natural Resource Sciences will participate in this training program over the next five years. Applicants for program come from leading Universities and Medical Schools from around the world. Our trainees have all either completed a residency program in internal medicine in the United States or received a PhD in a biological science at a major research University before enrolling in this fellowship. In this application, we request an increase in the number of our post-doctoral fellowship positions from three to four each year so we can support more PhD trained scientists interested in endocrinology as a career while continuing our long standing commitment to training physician scientists. These positions will be used to provide two years of support for 2 MD trained and two years of support for 2 PhD trained post-doctoral fellows selected for their outstanding potential to become leading scientists in diabetes, endocrinology, and metabolism each year.

Public Health Relevance

This research training program will prepare physician and PhD trained post-doctoral fellows to become investigators in the area of diabetes, endocrinology, and metabolism. We are experiencing an epidemic of diabetes and obesity worldwide and in the United States more than half of the population may be affected by these endocrine/metabolic diseases. Our public health demands that talented scientists determine why these diseases occur and develop new ways to prevent and treat them. As a result of the education and training obtained in this program, our fellows will be prepared to address these problems and improve the public health.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK007203-35
Application #
8481534
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Castle, Arthur
Project Start
1977-08-01
Project End
2017-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
35
Fiscal Year
2013
Total Cost
$168,611
Indirect Cost
$13,322
Name
University of Minnesota Twin Cities
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Bogachus, Lindsey D; Bellin, Melena D; Vella, Adrian et al. (2018) Deficient Glucagon Response to Hypoglycemia During a Mixed Meal in Total Pancreatectomy/Islet Autotransplantation Recipients. J Clin Endocrinol Metab 103:1522-1529
Osum, Kevin C; Burrack, Adam L; Martinov, Tijana et al. (2018) Interferon-gamma drives programmed death-ligand 1 expression on islet ? cells to limit T cell function during autoimmune diabetes. Sci Rep 8:8295
Burrack, Adam L; Landry, Laurie G; Siebert, Janet et al. (2018) Simultaneous Recognition of Allogeneic MHC and Cognate Autoantigen by Autoreactive T Cells in Transplant Rejection. J Immunol 200:1504-1512
Burrack, Adam L; Malhotra, Deepali; Dileepan, Thamotharampillai et al. (2018) Cutting Edge: Allograft Rejection Is Associated with Weak T Cell Responses to Many Different Graft Leukocyte-Derived Peptides. J Immunol 200:477-482
Muratore, Katherine A; Najt, Charles P; Livezey, Nicholas M et al. (2018) Sizing lipid droplets from adult and geriatric mouse liver tissue via nanoparticle tracking analysis. Anal Bioanal Chem 410:3629-3638
Bogachus, Lindsey D; Oseid, Elizabeth; Bellin, Melena et al. (2017) Deficient Endogenous Glucose Production During Exercise After Total Pancreatectomy/Islet Autotransplantation. J Clin Endocrinol Metab 102:3288-3295
Burrack, Adam L; Martinov, Tijana; Fife, Brian T (2017) T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes. Front Endocrinol (Lausanne) 8:343
Raymond, Christiana J; Bosch, Tyler A; Bush, Foster K et al. (2017) Accuracy and Reliability of Assessing Lateral Compartmental Leg Composition Using Dual-Energy X-ray Absorptiometry. Med Sci Sports Exerc 49:833-839
Robinson, Jerid W; Egbert, Jeremy R; Davydova, Julia et al. (2017) Dephosphorylation is the mechanism of fibroblast growth factor inhibition of guanylyl cyclase-B. Cell Signal 40:222-229
Shuhaibar, Leia C; Robinson, Jerid W; Vigone, Giulia et al. (2017) Dephosphorylation of the NPR2 guanylyl cyclase contributes to inhibition of bone growth by fibroblast growth factor. Elife 6:

Showing the most recent 10 out of 61 publications